What is the ticker symbol for Codexis?

Codexis trades under the ticker CDXS on NASDAQ.

What sector does Codexis operate in?

Codexis is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze CDXS in a portfolio?

PortView shows CDXS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Codexis (CDXS) Stock Analysis

NASDAQHealthcareBiotechnology

$1.51-0.33%

1-year price historyRange $0.98 – $2.85

52-week range$1.51

$0.96$2.98

What Codexis does

Codexis, Inc. is a biotechnology firm dedicated to the discovery, development, and commercialization of enzymes and other protein-based solutions. Its diverse portfolio encompasses advanced biocatalyst products and related services, specialized chemical intermediates vital for subsequent processing steps, and proprietary biocatalyst panels and kits that empower clients to conduct effective chemistry screening. The company also extends its expertise through biocatalyst screening and sophisticated protein engineering services. Central to its operations is the proprietary CodeEvolver protein engineering technology platform. This innovative platform is instrumental in crafting and delivering high-performance biocatalysts capable of driving chemical transformations, thereby significantly enhancing the efficiency and productivity of manufacturing processes. Beyond industrial applications, the CodeEvolver platform is also leveraged for identifying novel biotherapeutic drug candidates for targeted human diseases, as well as for developing enzymes essential for molecular biology research and in vitro diagnostic applications. Primarily serving pharmaceutical manufacturers, Codexis distributes its products through its dedicated direct sales and business development teams across the United States and Europe. Established in 2002, the company maintains its headquarters in Redwood City, California.

Key metrics

Market cap

$161.88M

P/E (TTM)

-4.43

EPS (TTM)

$-0.34

Beta

2.50

Dividend yield

0.00%

Revenue / share

$0.85

50-day avg

$1.89

200-day avg

$1.89

52-week high

$2.98

52-week low

$0.96

CEO

Alison Moore

ETFs linked to CDXS

Broad-market and Healthcare sector ETFs an investor holding Codexis is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how CDXS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CDXS in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Codexis?: Codexis trades under the ticker CDXS on NASDAQ.
Which exchange is CDXS listed on?: CDXS is listed on NASDAQ.
What sector does Codexis operate in?: Codexis is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze CDXS in a portfolio?: PortView shows CDXS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.